Breaking News Instant updates and real-time market news.

TSLA

Tesla

$356.04

0.48 (0.13%)

05:42
08/14/18
08/14
05:42
08/14/18
05:42

Tesla CEO Elon Musk says 'doesn't know' Azealia Banks, Gizmodo reports

Tesla CEO Elon Musk has responded to claims made by Azealia Banks, a rapper, singer, songwriter and actress, this week, saying he has "has never even met or communicated with her in any way," Gizmodo reports. Banks claims she spent the last few days at Musk's house in LA with his girlfriend Grimes, claiming that "I waited all weekend while grimes coddled her boyfriend for being too stupid to know not to go on twitter while on acid." Reference Link

  • 29

    Oct

TSLA Tesla
$356.04

0.48 (0.13%)

08/08/18
BARD
08/08/18
NO CHANGE
Target $411
BARD
Outperform
Tesla $420 buyout price mentioned by Musk too low, says Baird
Baird analyst Ben Kallo believes the Tesla buyout price of $420 mentioned by Elon Musk is too low. He expects the shares to trade above that mark as investors will demand a higher premium, which will coincide with short covering. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.
08/08/18
RBCM
08/08/18
NO CHANGE
Target $110
RBCM
Outperform
RBC Capital revisits idea of Celgene going private after Tesla proposal
Following yesterday's news that Tesla (TSLA) CEO Elon Musk would like to see his company go private, RBC analyst Brian Abrahams revisited his prior analysis of whether Celgene (CELG) should go private in order to better capture the medium-term value of future Revlimid cash flows not being appreciated by public markets and avoid volatility as it transitions to a post-Revlimid business model. Though acknowledging that the two companies are in completely different industries, he thinks the example of Musk shows that performing such a transaction on a large company "may not be completely unrealistic," Abrahams said. Such an LBO, or perhaps more likely an acquisition by a larger pharmaceutical company, could possibly help capture more value from Celgene's commercial and pipeline products, concludes Abrahams, who has an Outperform rating and $110 price target on Celgene shares.
08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.
08/10/18
MSCO
08/10/18
NO CHANGE
Target $291
MSCO
Equal Weight
Morgan Stanley says Tesla LBO doesn't seem feasible, equity buyout might be
Morgan Stanley analyst Adam Jonas said a leveraged buyout, or LBO, of Tesla does not appear to be feasible, even with less than $10B of incremental debt. However, he believes Tesla could consider an auction for its shares in the private equity market, financed by existing shareholders, new strategic investors, the possible divestiture of assets such as Tesla's autonomous and shared mobility assets and "possibly some help from SpaceX." However, Jonas notes that he has no knowledge of an equity buyout, or EBO, being considered by the company. He maintains an Equal Weight rating and $291 price target on Tesla shares.

TODAY'S FREE FLY STORIES

ELAN

Elanco

$31.76

-0.63 (-1.95%)

06:14
12/18/18
12/18
06:14
12/18/18
06:14
Hot Stocks
Elanco CEO says 'well positioned to grow top line revenue' »

"Our financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CS

Credit Suisse

$10.94

-0.155 (-1.40%)

06:14
12/18/18
12/18
06:14
12/18/18
06:14
Periodicals
Credit Suisse advises clients to mull shifting assets out of UK, FT reports »

Private bankers at Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

ELAN

Elanco

$31.76

-0.63 (-1.95%)

06:12
12/18/18
12/18
06:12
12/18/18
06:12
Earnings
Elanco sees FY19 adjusted EPS $1.02-$1.12 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ORCL

Oracle

$45.72

-0.9 (-1.93%)

06:12
12/18/18
12/18
06:12
12/18/18
06:12
Recommendations
Oracle analyst commentary  »

Oracle posted 'solid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDWR

Radware

$22.62

-0.17 (-0.75%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Hot Stocks
Radware announces deal with financial information technology provider »

Radware announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATGE

Adtalem Global Education

$50.01

-1.14 (-2.23%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Recommendations
Adtalem Global Education analyst commentary  »

Adtalem called a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$279.17

-8.54 (-2.97%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Periodicals
Japan to purchase 100 additional F-35 stealth fighters, FT reports »

Japan has said it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.76

-0.63 (-1.95%)

06:06
12/18/18
12/18
06:06
12/18/18
06:06
Earnings
Elanco reaffirms FY18 adjusted EPS view $1.14-$1.16, consensus $1.21 »

Reaffirms FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

HTGC

Hercules Capital

$10.83

-0.53 (-4.67%)

06:05
12/18/18
12/18
06:05
12/18/18
06:05
Hot Stocks
Hercules Capital announces $25M share repurchase program »

Hercules Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFR

Luxfer

$21.42

-1.26 (-5.56%)

06:03
12/18/18
12/18
06:03
12/18/18
06:03
Hot Stocks
Luxfer to acquire Neo Performance Materials for $612M in cash and stock »

Luxfer Holdings and Neo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$129.11

-3.75 (-2.82%)

06:02
12/18/18
12/18
06:02
12/18/18
06:02
Hot Stocks
J&J CEO Alex Gorsky: 'We know our talc is safe,' 'does not cause cancer' »

Johnson & Johnson CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

TPC

Tutor Perini

$16.63

-0.08 (-0.48%)

06:02
12/18/18
12/18
06:02
12/18/18
06:02
Hot Stocks
Tutor Perini subsidiary awarded $104M contract by Royal Saudi Air Force »

Tutor Perini announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPA

Copa Holdings

$75.17

-2.54 (-3.27%)

06:01
12/18/18
12/18
06:01
12/18/18
06:01
Initiation
Copa Holdings initiated  »

Copa Holdings reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFR

Luxfer

$21.42

-1.26 (-5.56%)

06:00
12/18/18
12/18
06:00
12/18/18
06:00
Hot Stocks
Breaking Hot Stocks news story on Luxfer »

Luxfer to acquire Neo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRO

Adecogro

$6.69

-0.35 (-4.97%)

06:00
12/18/18
12/18
06:00
12/18/18
06:00
Initiation
Adecogro initiated  »

Adecogro initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$348.30

-17.39 (-4.76%)

05:59
12/18/18
12/18
05:59
12/18/18
05:59
Periodicals
Musk's Boring Co. faces concerns over diversion of SpaceX resources, WSJ says »

Elon Musk's the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$129.11

-3.75 (-2.82%)

05:59
12/18/18
12/18
05:59
12/18/18
05:59
Periodicals
J&J looks to contain fallout from baby powder report with ads, Reuters reports »

Johnson & Johnson on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

EFX

Equifax

$97.25

0.06 (0.06%)

05:55
12/18/18
12/18
05:55
12/18/18
05:55
Conference/Events
Equifax to meet with investors »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

UNCFF

UniCredit

$0.00

(0.00%)

05:53
12/18/18
12/18
05:53
12/18/18
05:53
Hot Stocks
Italy's UniCredit settles dispute with Caius »

On August 6, UniCredit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLC

Taiwan Liposome

$6.01

(0.00%)

05:52
12/18/18
12/18
05:52
12/18/18
05:52
Hot Stocks
Taiwan Liposome announces full enrollment of TLC590 Phase I/II clinical trial »

Taiwan Liposome announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$207.01

-8.57 (-3.98%)

, INGN

Inogen

$125.96

-4.85 (-3.71%)

05:48
12/18/18
12/18
05:48
12/18/18
05:48
Recommendations
Align Technology, Inogen, Nuvectra, Intuitive Surgical, Merit Medical analyst commentary  »

Piper lays out top…

ALGN

Align Technology

$207.01

-8.57 (-3.98%)

INGN

Inogen

$125.96

-4.85 (-3.71%)

NVTR

Nuvectra

$16.27

-0.38 (-2.28%)

ISRG

Intuitive Surgical

$481.95

-9.89 (-2.01%)

MMSI

Merit Medical

$54.54

-1.79 (-3.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

ACHV

Achieve Life Sciences

$1.37

-0.07 (-4.86%)

05:45
12/18/18
12/18
05:45
12/18/18
05:45
Hot Stocks
Achieve Life Sciences: FDA confirms agreement with Initial Pediatric Study Plan »

Achieve Life Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MANU

Manchester United

$17.30

-0.2 (-1.14%)

05:39
12/18/18
12/18
05:39
12/18/18
05:39
Hot Stocks
Manchester United announces departure of manager Jose Mourinho »

Manchester United…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$255.12

-5.49 (-2.11%)

05:39
12/18/18
12/18
05:39
12/18/18
05:39
Periodicals
Ex-official thinks U.S., China can reach trade deal in 90 days, SCMP reports »

Zhu Min, who was deputy…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$255.12

-5.49 (-2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGA

Magna

$44.31

-1 (-2.21%)

05:38
12/18/18
12/18
05:38
12/18/18
05:38
Hot Stocks
Magna acquires VIZA Geca, terms not disclosed »

Magna signed an agreement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.